Safety and efficacy of convalescent plasma for severe COVID-19: a randomized, single blinded, parallel, controlled clinical study

BACKGROUND: Convalescent plasma (CP) has been widely used to treat COVID-19 and is under study. However, the variability in the current clinical trials has averted its wide use in the current pandemic. We aimed to evaluate the safety and efficacy of CP in severe coronavirus disease 2019 (COVID-19) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Rojas, Manuel, Rodríguez, Yhojan, Hernández, Juan Carlos, Díaz-Coronado, Juan C., Vergara, José Alejandro Daza, Vélez, Verónica Posada, Mancilla, Jessica Porras, Araujo, Iván, Yepes, Jairo Torres, Ricaurte, Oscar Briceño, Pardo-Oviedo, Juan Mauricio, Monsalve, Diana M., Acosta-Ampudia, Yeny, Ramírez-Santana, Carolina, García, Paula Gaviria, Landinez, Lina Acevedo, Correales, Luisa Duarte, Grass, Jeser Santiago, Pérez, Cristian Ricaurte, López, Gustavo Salguero, Mateus, Nataly, Mancera, Laura, Devia, Ronald Rengifo, Orjuela, Juan Esteban, Parra-Moreno, Christian R., Buitrago, Andrés Alfonso, Ordoñez, Inés Elvira, Osorio, Claudia Fabra, Ballesteros, Nathalia, Patiño, Luz H., Castañeda, Sergio, Muñoz, Marina, Ramírez, Juan David, Bastard, Paul, Gervais, Adrian, Bizien, Lucy, Casanova, Jean-Laurent, Camacho, Bernardo, Gallo, Juan Esteban, Gómez, Oscar, Rojas-Villarraga, Adriana, Pérez, Carlos E., Manrique, Rubén, Mantilla, Rubén D., Anaya, Juan-Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235185/
https://www.ncbi.nlm.nih.gov/pubmed/35761219
http://dx.doi.org/10.1186/s12879-022-07560-7

Ejemplares similares

Ejemplares similares